深圳市欣天科技股份有限公司 独立董事工作制度 二○二五年五月 1 第一章 总 则 第10条 公司董事会、单独或者合并持有公司已发行股份 1%以上的股东可以提出独 立董事候选人，并经股东会选举决定。上述提名人不得提名与其存在利害关 系的人员或者有其他可能影响独立履职情形的关系密切人员作为独立董事候 选人。 依法设立的投资者保护机构可以公开请求股东委托其代为行使提名独立董 事的权利。 3 第7条 公司董事会设立战略、提名、审计、薪酬和考核委员会，专门委员会成员全 部由董事组成，其中审计委员会的成员应当为不在公司担任高级管理人员的 董事；提名、审计、薪酬与考核委员会中独立董事应当过半数并担任召集人， 审计委员会的召集人应为会计专业人士。 第8条 独立董事应积极参加中国证监会、深圳证券交易所及中国上市公司协会等机 构所组织的培训，持续加强证券法律法规及规则的学习，不断提高履职能力。 2 第1条 为进一步完善深圳市欣天科技股份有限公司（以下简称"公司"）法人治理 结构，促进公司规范运作，维护公司整体利益，有效保障全体股东、特别是 中小股东的合法权益不受损害，强化对董事会和管理层的约束和监督，提高 公司决策的科学性和民主 ...

| | 资产对公司的债务承担责任。 | | | --- | --- | --- | | 5 | 第十条 本公司章程自生效之日起，即成为规范 | 第十条 本公司章程自生效之日起，即成为规范 | | | 公司的组织与行为、公司与股东、股东与股东之间 | 公司的组织与行为、公司与股东、股东与股东之 | | | 权利义务关系的具有法律约束力的文件，对公司、 | 间权利义务关系的具有法律约束力的文件，对公 | | | 股东、董事、监事、高级管理人员具有法律约束力 | 司、股东、董事、高级管理人员具有法律约束力的 | | | 的文件。依据本章程，股东可以起诉股东，股东可 | 文件。依据本章程，股东可以起诉股东，股东可以 | | | 以起诉公司董事、监事、总经理和其他高级管理人 | 起诉公司董事、总经理和其他高级管理人员，股 | | | 员，股东可以起诉公司，公司可以起诉股东、董 | 东可以起诉公司，公司可以起诉股东、董事、总经 | | | 事、监事、总经理和其他高级管理人员。 | 理和其他高级管理人员。 | | 6 | 第十五条 公司股份的发行，实行公开、公平、公 | 第十五条 公司股份的发行，实行公开、公平、公 | | ...

二〇二五年五月 1 深圳市欣天科技股份有限公司 董事和高级管理人员股份变动管理制度 第一章 总则 第一条 为加强深圳市欣天科技股份有限公司（以下简称"公司"或"本公司"）董 事、高级管理人员所持本公司股份及其变动的管理，维护证券市场秩序，根据《中华人 民共和国公司法》、《中华人民共和国证券法》、《上市公司收购管理办法》、《上市 公司董事和高级管理人员所持本公司股份及其变动管理规则（2025年修订）》、《深圳 证券交易所创业板股票上市规则》、《深圳证券交易所上市公司自律监管指引第10号— —股份变动管理》等有关法律、法规、规范性文件及《公司章程》的有关规定，结合公 司实际情况，制订本制度。 第二条 本制度适用于公司董事和高级管理人员。 公司董事和高级管理人员所持股份不超过1,000股的，可一次全部转让，不受前款 转让比例的限制。 第六条 公司董事和高级管理人员以上年末其所持有的本公司股份总数为基数，计算 其中可转让股份的数量。 董事和高级管理人员所持本公司股份年内增加的，新增无限售条件的股份当年可转 让25%，新增有限售条件的股份计入次年可转让股份的计算基数。 公司董事和高级管理人员所持本公司股份是指登记在其名 ...

Group 1: Research and Development Investment - In 2024, the company invested 25.82 million yuan in technology research and development, resulting in 2 invention patents and 18 utility model patents [2][3]. Group 2: Business Growth and Financial Performance - In Q1 2025, the company achieved operating revenue of 79,499,368.25 yuan, a year-on-year increase of 98.45%, and a net profit attributable to shareholders of -3,779,585.78 yuan, an increase of 55.14% compared to the previous year [3][4]. - The company aims to stabilize its overseas market while aggressively expanding its domestic market and developing new customer applications [3]. Group 3: Strategic Focus and Market Expansion - The company plans to focus on its second main business—core components for new energy, which accounted for over 25% of its business by 2024 [3]. - The construction of overseas production bases in Hungary and Vietnam is a priority, with the goal of reducing losses and enhancing the overseas business framework [3]. Group 4: Cost Control Measures - The company has implemented several cost control measures, including locking in prices for key raw materials, centralized procurement, and optimizing production processes to improve efficiency [4]. Group 5: Future Profit Growth Drivers - Future profit growth will be driven by the demand for mobile data traffic in the telecommunications industry and the growth of the new energy business, which is expected to enhance profitability through economies of scale [5].

Group 1 - Kexin Technology plans to repurchase shares worth between 30 million and 50 million yuan, with a maximum repurchase price of 80 yuan per share, for employee stock ownership plans or capital reduction [1] - Jiahua Technology's shareholder plans to reduce holdings by up to 1.5% of the company's total shares, amounting to a maximum of 116,000 shares, between May 28, 2025, and August 25, 2025 [1] - Beiqi Blue Valley's subsidiary reported cumulative sales of 38,041 vehicles this year, representing a year-on-year increase of 192.53% [2] Group 2 - AVIC Finance plans to transfer shares of AVIC Xi'an Aircraft Industry Group and AVIC Onboard Systems, totaling 4.067 billion yuan, to its controlling shareholder [2] - Haide shares' executives plan to increase their holdings by at least 20.73 million yuan within six months [3] - Dabeinong's subsidiary received planting approval for genetically modified soybeans in Brazil, marking significant progress in the South American market [4] Group 3 - Yongan Pharmaceutical's chairman is under investigation, but the company's operations remain normal [4] - Teruid's subsidiary is expected to win a 126 million yuan project from the State Grid, which will enhance the company's brand and industry influence [4][5] - Junxin shares plan to repurchase shares worth between 200 million and 300 million yuan, with a maximum price of 30.57 yuan per share [5] Group 4 - Meinian Health plans to reduce its holdings by up to 3% of the company's total shares, amounting to a maximum of 11.7 million shares, starting from May 27, 2025 [7] - Electric Power Investment is planning a major asset restructuring, leading to a temporary suspension of its stock [9] - Tongda shares are expected to win a 207 million yuan project from the State Grid, which will positively impact future operating performance [10] Group 5 - Xintian Technology's major shareholder plans to reduce holdings by up to 3% of the company's total shares, amounting to a maximum of 580,410 shares [11] - Huizhou Intelligent's controlling shareholder and some executives plan to increase their holdings by between 29.2 million and 58.4 million yuan [12] - Zhongdali De plans to sell a 50% stake in Shanghai Ketaike Transmission System Co., Ltd. for 9.2777 million yuan to optimize its asset structure [14] Group 6 - Jinlitai's stock will be suspended due to the inability to disclose periodic reports within the statutory deadline [15] - Chuhuan Technology's major shareholder plans to reduce holdings by up to 3% of the company's total shares, amounting to a maximum of 239,560 shares [15] - Guilin Sanjin's subsidiary received approval for clinical trials of a new indication for a monoclonal antibody injection [16] Group 7 - Plit plans to sign a strategic supply agreement for sodium-ion batteries, committing to supply at least 1 GWh over four years [17] - Dalian Electric Porcelain's subsidiary is expected to win a project worth approximately 71 million yuan from the State Grid [18]

Group 1 - Major shareholders of *ST WanFang plan to reduce their holdings by up to 9,341,596 shares, accounting for 3% of the company's total share capital from May 27 to August 25, 2025 [1] - Shareholders of Airo Energy intend to reduce their holdings by up to 800,000 shares, 800,000 shares, and 1,600,000 shares, representing 0.50%, 0.50%, and 1% of the company's total share capital respectively during the same period [1] - Anner plans to reduce its holdings by up to 3,186,159 shares, which is 1.5% of the company's total share capital, from May 27 to August 26, 2025 [1] Group 2 - Shareholders of Chuhuan Technology plan to reduce their holdings by up to 2,395,605 shares, accounting for 3% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [1] - Major shareholder of Dalian Technology intends to reduce their holdings by up to 4,189,336 shares, which is 0.99% of the company's total share capital from May 27 to August 26, 2025 [2] - Dongwei Technology's board members plan to reduce their holdings by a total of 2,574,857 shares, representing 0.8629% of the company's total share capital during the same period [2] Group 3 - Gann Li Pharmaceutical's shareholder has completed a reduction of 6,010,622 shares, which is 1% of the company's total share capital from April 22 to April 30, 2025 [2] - Guanshi Technology's board members plan to reduce their holdings by up to 359,375 shares, accounting for 0.4891% of the company's total share capital from May 27 to August 26, 2025 [2] - Guoguang Electric's shareholder has completed a reduction of 1,625,751 shares, which is 1.5% of the company's total share capital from April 25 to April 30, 2025 [2] Group 4 - Haili Biological's major shareholder has completed a reduction of 13,113,244 shares, representing 2% of the company's total share capital from April 15 to April 22, 2025 [3] - Hengfeng Information's board member has completed a reduction of 198,717 shares, which is 0.1207% of the company's total share capital on April 28, 2025 [3] - Hongwei Technology's shareholder plans to reduce their holdings by up to 820,000 shares, accounting for 0.39% of the company's total share capital from May 12 to August 11, 2025 [3] Group 5 - Huatai Medical's vice president has completed a reduction of 29,943 shares, which is 0.0308% of the company's total share capital from April 28 to April 29, 2025 [4] - Jilin Carbon Valley's major shareholder has completed a reduction of 4,989,160 shares, representing 0.8490% of the company's total share capital from April 25 to April 29, 2025 [4] - Jiahua Technology's shareholder plans to reduce their holdings by up to 1,160,000 shares, accounting for 1.50% of the company's total share capital from May 28 to August 25, 2025 [4] Group 6 - Jiangbo Long's shareholder plans to reduce their holdings by up to 4,159,815 shares, which is 1% of the company's total share capital from May 27 to August 26, 2025 [5] - Jiangshan Co. plans to reduce its holdings in Jiangtian Chemical by 4,330,800 shares, accounting for 3% of its total share capital from May 27 to August 26, 2025 [5] - Kairun Co.'s major shareholder plans to reduce their holdings by up to 9,000,000 shares, representing 2.43% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [5] Group 7 - Lianqi Technology's shareholders plan to reduce their holdings by a total of 18,717,374 shares, which is 2.96% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [9] - Zhongke Information's board members have completed a reduction of 698,914 shares, representing 0.2358% of the company's total share capital [9] - Zhongshi Co.'s major shareholder plans to reduce their holdings by up to 1,800,000 shares, accounting for 1.1527% of the company's total share capital from May 27 to August 26, 2025 [10]

欣天科技(300615.SZ)公告称，持股9.15%的股东薛枫因个人资金需要，计划在未来3个月内，以集中竞 价或大宗交易方式合计减持公司股份不超过5,804,076股，占公司总股本的3%。减持期间为2025年5月27 日至8月26日。 ...

持本公司股份 17,702,112 股（占本公司总股本比例 9.15%）的持股 5%以上股 东薛枫先生因个人资金需要，计划在本次减持计划预披露公告之日起 15 个交易 日后 3 个月内，以集中竞价或大宗交易方式合计减持公司股份不超过 5,804,076 股 （占公司总股本的比例约为 3%）。 深圳市欣天科技股份有限公司（以下简称"公司"或"欣天科技"）收到持股 5%以上股东薛枫先生出具的《关于股份减持计划的告知函》，现将有关情况公告 如下： 证券代码：300615 证券简称：欣天科技 公告编号：2025-038 深圳市欣天科技股份有限公司 关于持股 5%以上股东减持股份的预披露公告 公司持股 5%以上股东薛枫先生保证向本公司提供的信息内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 一、股东基本情况 | 股东 | 持有公司股份数量（股） | 占公司总股本的比例 | | --- | --- | --- | | 薛枫 | 17,702,112 | 9.15% | 二、本次减持计划的主要内容 1、减持原因：个人资金需要 2、 ...

Core Viewpoint - Xintian Technology (欣天科技) reported a significant decline in its 2024 annual performance, with total revenue dropping to 277 million yuan, a year-on-year decrease of 55.02%, and a net profit loss of 18 million yuan, reflecting a staggering year-on-year decline of 130.38% [1][4]. Group 1: Performance Overview - The company's total revenue for 2024 was 277 million yuan, down 55.02% year-on-year [1]. - The net profit attributable to shareholders was -18 million yuan, a year-on-year drop of 130.38% [1]. - The non-recurring net profit was -23.17 million yuan, representing a 143.12% decline year-on-year [1]. Group 2: Market Conditions - The slowdown in global 5G network construction, particularly in Europe and the United States, has adversely affected the company's communication business [4]. - Sales volume of communication products decreased by 54.28% year-on-year, with main business revenue declining by 55.85% [4]. - The stagnation of projects in the Indian market significantly impacted the company's performance, as previous infrastructure expansion had driven growth [4]. Group 3: Emerging Business Challenges - Although there was growth in the product lines related to new energy and medical devices, these businesses have not yet achieved scale effects, contributing minimally to overall performance [5]. - Production capacity for new energy and medical components remained stable compared to the previous year, but sales and revenue did not meet expectations [5]. - The potential for new energy and medical products to become new growth points remains uncertain and requires time for market expansion [5]. Group 4: Cost and Profitability Issues - The company faced increased cost control pressures due to rising raw material prices, leading to higher operating costs and reduced profit margins [6]. - The comprehensive gross margin decreased by 7.35% year-on-year, reaching 21.68% [6]. - Period expenses increased, with sales expenses rising by 102.63 thousand yuan and management expenses increasing by 225.45 thousand yuan, primarily due to higher depreciation and amortization costs [6].

证券代码：300615 证券简称：欣天科技 公告编号：2025-029 深圳市欣天科技股份有限公司 关于预计公司 2025 年度日常关联交易的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、 日常关联交易的基本情况 （一）关联交易概述 深圳市欣天科技股份有限公司（以下简称"公司"）及其合并范围内下属子公 司根据日常经营需要，预计在 2025 年度将与公司关联方东莞鸿爱斯通信科技有 限公司（以下简称"东莞鸿爱斯"）、南京晶萃光学科技有限公司（以下简称"晶 萃光学"）发生日常经营性关联交易，交易金额合计不超过 3,600 万元。 2025 年 4 月 18 日，公司召开了第五届董事会第二次会议及第四届监事会第 二十二次会议，审议通过了《关于预计 2025 年度日常关联交易的议案》，关联董 事孙海龙先生已回避表决。本次关联交易事项在提交董事会审议前已经公司第四 届董事会独立董事专门会议 2025 年第一次会议审议和第四届审计委员会 2025 年 第一次会议审议，并经全体独立董事过半数同意。 根据《深圳证券交易所创业板股票上市规则（2024 年修订）》和《公 ...